1. Introduction
1.1. Market Overview
1.2. Market Definition
1.3. Scope Of The Study
1.4. Currency
1.5. Assumptions
1.6. Base, And Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
3. Executive Summary
4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. Smoking Cessation Market By Therapy
5.1. Nicotine Replacement Therapy
5.2. Non-Nicotine Replacement Therapy
6. Smoking Cessation Market By Product Type
6.1. Chewing Gum
6.2. Patches
6.3. Sprays And Inhalers
6.4. E-Cigarettes
6.5. Others
7. Smoking Cessation Market By Geography
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East And Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others
8. Competitive Intelligence
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments And Deals
8.3. Strategies of Key Players
9. Company Profiles
9.1. GSK Group of Companies
9.2. Dr. Reddy’s Laboratories Ltd.
9.3. Cipla Inc.
9.4. Chrono Therapeutics Inc.
9.5. Invion Limited
9.6. Selecta Biosciences, Inc.
9.7. Achieve Life Sciences, Inc.
9.8. Lotus
9.9. Ethismos Research Inc.
LIST OF FIGURES
LIST OF TABLES